BlissCo Cannabis Corp. (CSE: BLIS) ("BlissCo" or the "Company") is pleased to announce that the Company's wholly-owned subsidiary, Bliss Co Holdings Ltd. ("BlissCo") has been granted a licence by Health Canada to cultivate cannabis plants and prepare dried cannabis.
Phivida Holdings Inc. is pleased to announce that it has filed and obtained a receipt for its final long form prospectus dated November 21, 2017 from the securities regulatory authorities in British Columbia and Ontario.
Aurora Cannabis Inc. (ACB.TO) (ACBFF) continues to execute and advance its business model as Canada prepares to legalize recreational cannabis and the market has taken notice of this.
For the second time in ten days, Canaccord Genuity raised its price target on the Canadian medical marijuana producer. Today, Canaccord raised its price target on Aurora to $4.45 from $3.65 (on November 2nd, Canaccord raised it to $3.65 from $3.25).
Emerald Health Pharmaceuticals Inc. (EHP), which is developing medications based on cannabinoid science, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for its lead molecule, EHP-101, for the treatment of systemic scleroderma. This chronic autoimmune disease causes severe fibrosis of the skin and internal organs and is associated with significant morbidity and mortality.
From quarterly earnings to production capacity expansions, Canadian cannabis companies continue to execute and work toward delivering value to its shareholder.
Although companies levered to this burgeoning opportunity have been under significant pressure, we believe the industry is nearing a bottom and this will create several opportunities for strategic investors.
Brad Trost, a Conservative leadership candidate who says he does not believe climate change, opposes transgender rights, gay marriage and abortion, has a new target…cannabis
Trost has sponsored a petition to repeal the Cannabis Act which was submitted to the House of Commons last month. The petition opened on May 8th and has less than 1,500 signatures but this guys must be stopped in his tracks.
The Canadian cannabis industry continues to be one of the hottest places to invest as the country prepares to become the first G-7 nation to legalize recreational cannabis.
WeedMD Inc. came roaring out of the gates yesterday when it commenced trading on the TSX Venture Exchange under the symbol WMD.V.
WeedMD is a licensed producer of medical cannabis under the ACMPR and plans to be Canada’s first producer focused on the long-term and retirement sector by leveraging its deep industry relationships and expertise.
Despite the Dow rallying another 220 points and the Nasdaq ending the day above the 6,000, Canadian cannabis stocks were under pressure.
This pressure accelerated throughout the day and followed this tweet from President Trump, “Canada has made business for our dairy farmers in Wisconsin and other border states very difficult. We will not stand for this. Watch!”
Canadian stocks levered to the emerging cannabis industry have been on watch after the Canadian Federal government tabled the Cannabis Act last week.
This legislation will create a legal recreational cannabis market in Canada before July 1, 2018. Following the introduction of the Cannabis Act, the market has seen series of significant company developments as these companies work to put themselves in a position to capitalize on this multi-billion-dollar opportunity.